Category: Vaccine

PREMIERING 7:30PM ET: Robert F. Kennedy Jr. (Part 1): The Dark Secrets of the Childhood Immunization Schedule and the Vaccine Approval Process

“You have scientists who are supposed to be regulators who are actually making money on the product that they’re supposed to be regulating.” Robert F. Kennedy Jr., the founder and chief legal counsel of Children’s Health Defense and author of “The Real Anthony Fauci,” shares his journey from environmental activist to a fierce critic of the…


PREMIERING 3/11 at 7:30PM ET: Robert F. Kennedy Jr. (Part 1): The Dark Secrets of the Childhood Immunization Schedule and the Vaccine Approval Process

“You have scientists who are supposed to be regulators who are actually making money on the product that they’re supposed to be regulating.” Robert F. Kennedy Jr., the founder and chief legal counsel of Children’s Health Defense and author of “The Real Anthony Fauci,” shares his journey from environmental activist to a fierce critic of the…


[SUNDAY WATCH PARTY] Dr. Aseem Malhotra: From Vaccine Pusher to Vaccine Debunker—How I Changed My Mind About the COVID-19 Jab

Join us for our ATL Sunday Watch Party! During the Watch Party this Sunday at 7:30pm ET, everyone can watch part one of our episode with Dr. Aseem Malhotra for FREE—even without a subscription. Feel free to share this link with your friends and family! This episode was originally published in Dec 10, 2022. “Once…


Woody Harrelson Demonstrates the Pain of Truth

Commentary In the course of an otherwise unmeaningful monologue on Saturday Night Live, Woody Harrelson let go with a remarkable theory of the COVID era. It was supposed to be hilarious but why should it be? In a world in which people were long over this, all the investigations have been done and the condemnations…


Taiwan to Pay Family of Child Who Died After 2 Doses of COVID Vaccine

Taiwan’s government will grant 3.5 million New Taiwan Dollars (about $114,000) to the family of a child who died of sudden myocarditis after receiving a second dose of the Pfizer-BioNtech COVID-19 vaccine, an official said on Sunday. Central Epidemic Command Center (CECC) spokesperson Lo Yi-chun said the family was among the 10 applicants eligible for…


FDA Finds Rare Neurological Disorder Is a ‘Potential Risk’ With Pfizer Vaccine

The Food and Drug Administration (FDA) said two people who received Pfizer’s respiratory syncytial virus (RSV) vaccine during a clinical trial were subsequently diagnosed with a rare neurological disorder known as Guillain-Barre syndrome. Briefing documents (pdf) released on Feb. 24 ahead of an upcoming meeting of the Vaccines and Related Biological Products Advisory Committee flagged…


FDA Finds Rare Neurological Disorder Is a ‘Potential Risk’ With Pfizer RSV Vaccine

The Food and Drug Administration (FDA) said two people who received Pfizer’s respiratory syncytial virus (RSV) vaccine during a clinical trial were subsequently diagnosed with a rare neurological disorder known as Guillain-Barre syndrome. Briefing documents (pdf) released on Feb. 24 ahead of an upcoming meeting of the Vaccines and Related Biological Products Advisory Committee flagged…


FDA Finds Rare Neurological Disorder Is ‘Potential Risk’ With Pfizer RSV Vaccine

The Food and Drug Administration (FDA) stated that two older adults who received Pfizer’s respiratory syncytial virus (RSV) vaccine during a clinical trial were subsequently diagnosed with a rare neurological disorder known as Guillain-Barré syndrome. Briefing documents (pdf) released on Feb. 24 ahead of this week’s meeting of the Vaccines and Related Biological Products Advisory…


US Government Received $400 Million in COVID-19 Vaccine Royalty Payments: Moderna

Moderna said on Feb. 23 that it recently reached a patent agreement with the U.S. government over disputed technology that is featured in its COVID-19 vaccine. In December 2022, Moderna entered “a nonexclusive patent license agreement” with the National Institute of Allergy and Infectious Diseases (NIAID), said CFO Jamey Mock during an earnings call on Thursday….


Merck’s COVID-19 Drug Fails to Show ‘Statistically Significant Reduction’ in Infection Risk

The phase 3 clinical trial of Merck’s COVID-19 antiviral molnupiravir, branded as Lagevrio, has ended up in failure, as participants who took the medication did not exhibit any significant reduction in the risk of contracting the illness. The trial was conducted among 1,500 participants who randomly received Lagevrio or a placebo orally every 12 hours…